HIKALPharmaceuticals

Hikal LtdCash Flow Statement

147.08
-6.80%

Hikal Ltd Cash Flow Statement (Annual)

Metric20252024202320222021
Free Cash Flow143.10 Cr-17.50 Cr12.69 Cr20.42 Cr
Repayment Of Debt-103.30 Cr-83.70 Cr-121.23 Cr-88.71 Cr
Issuance Of Debt75.00 Cr35.00 Cr290.00 Cr135.00 Cr
Capital Expenditure-137.30 Cr-204.20 Cr-302.62 Cr-273.31 Cr
End Cash Position13.00 Cr12.70 Cr26.73 Cr11.40 Cr
Beginning Cash Position12.70 Cr26.70 Cr11.44 Cr7.60 Cr
Changes In Cash0.30 Cr-14.00 Cr15.29 Cr3.80 Cr
Financing Cash Flow-143.60 Cr-27.00 Cr-7.68 Cr-5.56 Cr
Interest Paid Cff-75.00 Cr-78.40 Cr-64.49 Cr-44.88 Cr
Cash Dividends Paid-14.80 Cr-14.80 Cr-12.33 Cr-27.13 Cr
Net Issuance Payments Of Debt-53.50 Cr66.50 Cr69.49 Cr66.75 Cr
Net Short Term Debt Issuance-25.20 Cr115.20 Cr-99.28 Cr20.46 Cr
Net Long Term Debt Issuance-28.30 Cr-48.70 Cr168.77 Cr46.29 Cr
Long Term Debt Payments-103.30 Cr-83.70 Cr-121.23 Cr-88.71 Cr
Long Term Debt Issuance75.00 Cr35.00 Cr290.00 Cr135.00 Cr
Investing Cash Flow-136.50 Cr-173.70 Cr-292.34 Cr-284.37 Cr
Net Other Investing Changes2.90 Cr28.00 Cr0.84 Cr-3.12 Cr
Interest Received Cfi0.70 Cr1.90 Cr1.90 Cr1.69 Cr
Net Investment Purchase And Sale-3.70 Cr0.40 Cr6.96 Cr-9.90 Cr
Sale Of Investment0.40 Cr0.40 Cr11.59 Cr8.14 Cr
Purchase Of Investment-4.10 Cr0.00-4.62 Cr-18.04 Cr
Net PPE Purchase And Sale-136.40 Cr-204.00 Cr-302.05 Cr-273.05 Cr
Sale Of PPE0.90 Cr0.20 Cr0.57 Cr0.27 Cr
Purchase Of PPE-137.30 Cr-204.20 Cr-302.62 Cr-273.31 Cr
Operating Cash Flow280.40 Cr186.70 Cr315.31 Cr293.73 Cr
Taxes Refund Paid-29.80 Cr-30.30 Cr-28.80 Cr-69.80 Cr
Change In Working Capital-28.70 Cr-53.40 Cr75.61 Cr18.70 Cr
Change In Payable25.20 Cr-34.20 Cr64.95 Cr19.36 Cr
Change In Inventory-32.40 Cr11.00 Cr8.23 Cr-63.42 Cr
Change In Receivables-11.50 Cr-52.50 Cr14.20 Cr-9.56 Cr
Other Non Cash Items74.50 Cr54.70 Cr43.59 Cr27.83 Cr
Provisionand Write Offof Assets4.70 Cr4.10 Cr8.48 Cr2.67 Cr
Depreciation And Amortization134.40 Cr117.60 Cr109.01 Cr95.67 Cr
Depreciation134.40 Cr117.60 Cr108.42 Cr94.95 Cr
Gain Loss On Investment Securities-0.40 Cr-0.40 Cr-1.32 Cr-0.37 Cr
Net Foreign Currency Exchange Gain Loss1.40 Cr-0.70 Cr2.50 Cr0.89 Cr
Gain Loss On Sale Of PPE-0.10 Cr-0.20 Cr0.70 Cr-0.05 Cr
Net Income From Continuing Operations123.80 Cr95.50 Cr105.36 Cr218.56 Cr
Dividends Received Cfi20000.000.000.0010000.00
Amortization Cash Flow1.63 Cr0.59 Cr0.71 Cr0.74 Cr
Other Cash Adjustment Outside Changein Cash0.01 Cr-40000.00-10000.00
Common Stock Dividend Paid-27.13 Cr-14.82 Cr
Short Term Debt Issuance20.46 Cr
Short Term Debt Payments-5.69 Cr

All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.